BiomarkersReview

Interpreting TP53 pathogenic variants in germline testing and cancer genomics: pathogenicity, origin, and clinical actionability

Japanese Journal of Clinical Oncology

The paper

Issei Imoto, Nobue Takaiso, Akiyo Yoshimura

Aichi Cancer Center

Japanese Journal of Clinical Oncology · 30 Sep 2026

doi.org/10.1093/jjco/hyag158 PubMed 42814862

Partial Y chromosome loss alters transcription in cancer cells
Communications Biology · 4 Oct 2026
MUTYH protects telomeres from chronic oxidative damage in cancer cells
Biomolecules · 3 Oct 2026
Clonal hematopoiesis remodels human bone marrow into an inflammatory prefibrotic environment
Nature Immunology · 2 Oct 2026
Plasma proteomics reveals pre-diagnostic markers for 25 cancers
medRxiv · 4 Oct 2026